دورية أكاديمية

RETRACTED ARTICLE: Comparison of two FDA-approved interspinous spacers for treatment of lumbar spinal stenosis: Superion versus X-STOP—a meta-analysis from five randomized controlled trial studies

التفاصيل البيبلوغرافية
العنوان: RETRACTED ARTICLE: Comparison of two FDA-approved interspinous spacers for treatment of lumbar spinal stenosis: Superion versus X-STOP—a meta-analysis from five randomized controlled trial studies
المؤلفون: He Zhao, Li-Jun Duan, Yu-Shan Gao, Yong-Dong Yang, Ding-Yan Zhao, Xiang-Sheng Tang, Zhen-guo Hu, Chuan-Hong Li, Si-Xue Chen, Tao Liu, Xing Yu
المصدر: Journal of Orthopaedic Surgery and Research, Vol 13, Iss 1, Pp 1-8 (2018)
بيانات النشر: BMC, 2018.
سنة النشر: 2018
المجموعة: LCC:Orthopedic surgery
LCC:Diseases of the musculoskeletal system
مصطلحات موضوعية: Superion, X-STOP, Follow-up, Meta-analysis, Orthopedic surgery, RD701-811, Diseases of the musculoskeletal system, RC925-935
الوصف: Abstract Background Decompressive laminectomy (DI) is a standard operation for lumbar spinal stenosis (LSS) patient with severe claudication symptoms for many years. However, patients whose symptom severity does not meet undergoing invasive surgery make therapeutic options into dilemma. Interspinous spacers (ISP) bridge the gap between surgical interventions and CC in management of LSS. In our study, we aim to systematically assess the two FDA-approved interspinous spacers for treatment of lumbar spinal stenosis: Superion versus X-STOP. Methods Electronic databases, including PubMed, Embase, MEDLINE, Cochrane Library were searched to retrieve clinical trials concerning the comparison between Superion and X-STOP in treatment for lumbar spinal stenosis before April 2017. The following outcome measures were extracted: (1) Zurich Claudication Questionnaire (ZCQ) patient satisfaction score, (2) axial pain severity, (3) extremity pain severity, (4) back-specific functional impairment, (5) reoperation, and (6) complication. The data analysis was conducted with Review Manager 5.3. Results Five randomized controlled trials (RCTs) with 1118 patients were included in this meta-analysis. The pooled analysis indicated that the Superion group is superior to X-STOP in axial pain severity (SMD: 0.03; 95% CI 0.15, 0.45; p
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1749-799X
Relation: http://link.springer.com/article/10.1186/s13018-018-0742-0; https://doaj.org/toc/1749-799X
DOI: 10.1186/s13018-018-0742-0
URL الوصول: https://doaj.org/article/d2ed16d7bd444e86acdd63bb299484ed
رقم الأكسشن: edsdoj.2ed16d7bd444e86acdd63bb299484ed
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:1749799X
DOI:10.1186/s13018-018-0742-0